Moderna raises 2021 vaccine output forecast to at least 600 million doses

FILE PHOTO: Vials and medical syringe are seen in front of Moderna logo in this illustration
FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration

January 4, 2021

(Reuters) – Moderna Inc said on Monday it would produce at least 600 million doses of its COVID-19 vaccine in 2021, up by 100 million doses from its previous forecast, as the United States continues to roll-out the vaccine.

The company was working to invest and hire in order to deliver up to 1 billion doses this year, the higher end of its production forecast, it said.

Moderna said it has so far supplied about 18 million doses to U.S. government as part of a deal for 200 million doses. It has also signed a deal with the Canadian government for 40 million doses.

(This story refiles to add dropped word in paragraph two)

(Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur)